MOTS-C in Mui Ne: What Is Known About Mitochondrial Peptides and Thermoregulatory Research?
Featured Answer: What Is Known About MOTS-c and Thermoregulation?
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded by a short open reading frame in the mitochondrial 12S ribosomal RNA region. Experimental studies have linked it to metabolic regulation, AMP-activated protein kinase (AMPK) signaling, and cellular stress responses. Research reviews also describe changes in endogenous mitochondrial-derived peptides in response to exercise and other physiological stressors.
Thermoregulation is the process by which the body balances heat production and heat loss. Exercise in a hot environment increases the demands on circulation and temperature control, often increasing skin blood flow and sweating. These responses are well established in human exercise physiology.
The evidence gap is important: research connecting MOTS-c with metabolic stress does not establish that MOTS-c directly controls human body temperature, improves heat tolerance, prevents heat illness, or makes exercise safer in Mui Ne. No established human clinical evidence demonstrates those outcomes for an administered MOTS-c product.
The most defensible scientific interpretation is that MOTS-c is a candidate component of mitochondrial stress signaling worth investigating, while thermoregulation remains a separate, well-characterized physiological system. Whether the two interact in a clinically meaningful way requires direct research.
Key Takeaways
- MOTS-c is a mitochondrial-derived peptide. Its 16-amino-acid sequence is encoded within mitochondrial DNA, and it has been investigated as a signaling molecule involved in metabolic homeostasis.
- AMPK is a proposed mechanistic link. Experimental research connects MOTS-c with the folate–AICAR–AMPK pathway, which participates in cellular energy sensing.
- Mitochondrial signaling is not the same as heat regulation. A cellular stress response does not automatically establish an effect on sweating, core temperature, or heat tolerance.
- Exercise can affect endogenous mitochondrial-derived peptides. Some studies report acute responses to exercise, but results vary by peptide, tissue, protocol, and measurement method.
- Heat stress has an established physiological profile. Skin blood flow and sweating increase to help dissipate heat, while dehydration can increase cardiovascular and thermal strain.
- Direct MOTS-c evidence in human thermoregulation is lacking. A validated effect on human core temperature, sweat rate, heat acclimatization, or heat-illness risk has not been established.
- Animal findings are hypothesis-generating. Results from experimental models cannot establish clinical benefits or an appropriate human dose.
- Product quality and human safety remain important uncertainties. A product described as research-grade is not automatically equivalent to material used in a published study or suitable for human administration.
1. Introduction: Two Scientific Questions That Should Not Be Confused
Exercise in a warm coastal environment such as Mui Ne creates a familiar physiological challenge. Muscles consume energy, metabolism produces heat, circulation must support both working tissue and temperature regulation, and sweating helps transfer heat away from the body.
At the same time, mitochondrial biology has become an important area of research into how cells sense energy demand and respond to stress. Mitochondrial-derived peptides, including MOTS-c, are of interest because they may participate in signaling between mitochondria and other parts of the cell.
These topics overlap at the broad level of stress physiology, but they are not interchangeable. A molecule associated with cellular energy regulation is not necessarily a regulator of whole-body temperature. Similarly, a peptide that affects a metabolic pathway in an experimental model is not automatically a treatment for heat-related physiological strain.
To understand what MOTS-c may contribute to thermoregulatory research, it is useful to separate three evidence areas:
- Mitochondrial peptide biology: how MOTS-c is encoded, detected, and studied as a signaling molecule.
- Exercise and metabolic stress: how exercise can alter endogenous mitochondrial-derived peptide responses and cellular signaling.
- Thermoregulation: how humans regulate body temperature during exercise and how heat exposure affects performance and safety.
The central question is whether research has established a direct causal connection between administered MOTS-c and human thermoregulation. At present, that connection remains unproven.
2. What Are Mitochondrial-Derived Peptides?
Mitochondria contain their own genome and participate in energy production, redox regulation, and cellular signaling. Although mitochondrial DNA is best known for encoding proteins and RNA components involved in mitochondrial function, researchers have also identified short open reading frames that encode small peptides.
These molecules are known as mitochondrial-derived peptides (MDPs). They are being studied as potential signals through which mitochondrial status can influence processes elsewhere in the cell or, potentially, in other tissues.
MOTS-c is one member of this group. Other studied mitochondrial-derived peptides include humanin and small humanin-like peptides (SHLPs). These peptides are distinct molecules with different sequences and evidence bases; findings for one should not automatically be attributed to another.
2.1 MOTS-c and its mitochondrial origin
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c. It is a 16-amino-acid peptide encoded within the mitochondrial MT-RNR1 region, which also encodes mitochondrial 12S ribosomal RNA.
The original discovery research, published by Lee and colleagues in Cell Metabolism in 2015, identified MOTS-c as a candidate metabolic signaling peptide and reported effects in experimental systems related to glucose regulation and metabolic homeostasis.
Subsequent research has explored potential links with insulin sensitivity, aging-related processes, exercise, and stress responses. However, the strength of evidence differs considerably across these topics.
2.2 A peptide signal is not a direct measurement of mitochondrial performance
MOTS-c is not ATP, an enzyme that directly produces ATP, or a validated standalone measure of mitochondrial efficiency. It is studied as a signaling molecule that may influence cellular responses.
Detecting MOTS-c or observing a change in its concentration does not by itself demonstrate that mitochondria are producing more ATP, that a person can exercise longer, or that body temperature is better controlled.
These outcomes require their own measurements and appropriate study designs.
3. How Is MOTS-c Linked to Cellular Energy Stress?
AMP-activated protein kinase (AMPK) is a cellular energy sensor involved in coordinating energy use and production. It responds to changes in cellular energy status and influences processes such as glucose uptake, lipid metabolism, and other aspects of metabolic regulation.
The original MOTS-c study reported a relationship between the peptide and the folate–AICAR–AMPK pathway. In the experimental model, changes in folate-cycle and purine-biosynthesis activity were associated with AICAR-related signaling and AMPK activation.
This mechanism offers a plausible explanation for some of the metabolic effects reported in experimental research. It does not mean that MOTS-c is a universal switch for cellular stress or that every response involving AMPK is beneficial.
3.1 What the proposed pathway means
Folate metabolism and purine biosynthesis are interconnected biochemical processes. Changes in these pathways can affect the availability of metabolites involved in cellular regulation. AMPK, in turn, participates in coordinating cellular responses when energy demand and energy availability change.
Research has therefore investigated whether MOTS-c can influence how cells respond to metabolic challenges. Experimental findings have helped generate hypotheses about glucose handling, insulin sensitivity, and metabolic adaptation.
However, an effect on this pathway does not establish a direct effect on the hypothalamus, sweating mechanisms, skin blood flow, or the physiological control of core body temperature.
3.2 Cellular stress and whole-body stress are different levels of analysis
Cellular energy stress describes conditions affecting energy balance within cells. Exercise and heat exposure, by contrast, can place demands on multiple systems at once, including cardiovascular, respiratory, muscular, endocrine, and thermoregulatory systems.
A peptide that affects cellular metabolism could eventually prove relevant to some aspects of whole-body adaptation. But that possibility must be tested rather than assumed.
A molecular pathway can explain how a biological effect might occur, but it cannot establish a clinical outcome on its own. For MOTS-c, evidence involving AMPK-related signaling does not demonstrate that administering the peptide improves sweating efficiency, lowers core temperature, or prevents heat illness in humans.
4. What Does Research Say About MOTS-c and Exercise?
Exercise increases energy demand in working muscles and changes multiple signaling pathways. Some of these changes are short-lived responses to a single session; others may contribute to adaptations that develop with repeated training.
A review by Merry and colleagues, published in Biochimica et Biophysica Acta – General Subjects in 2021, examined the evidence for mitochondrial-derived peptides as exercise-responsive signals. The review discussed observations that acute exercise can alter endogenous MDP expression or circulating levels, including reports involving MOTS-c.
However, the findings differ according to the peptide measured, the tissue or biological sample, the exercise protocol, and the timing of measurement. Evidence that a peptide changes after exercise is not the same as evidence that the peptide causes the benefits of exercise.
4.1 Acute responses versus training adaptations
An acute exercise response is a temporary change that occurs during or shortly after a session. A training adaptation is a longer-term physiological change that emerges after repeated exposure to exercise.
Researchers may measure a change in a peptide after one exercise session and then investigate whether it is associated with metabolic or performance outcomes. But a correlation between peptide concentration and exercise does not establish that the peptide is responsible for the adaptation.
To establish a causal role, research needs appropriate interventions and controls, along with reliable measurements of the outcomes in question.
4.2 Endogenous MOTS-c is not equivalent to an administered peptide
Endogenous MOTS-c is produced within the biological system. An administered MOTS-c product introduces additional questions about its identity, formulation, exposure, distribution, metabolism, and biological activity.
A study showing that endogenous MOTS-c changes during exercise cannot determine whether an externally administered peptide reproduces that response. Nor does it establish the safety or efficacy of a commercial product carrying the MOTS-c name.
These questions require direct studies of the administered material, with appropriate characterization and human safety monitoring.
5. What Is Thermoregulation?
Thermoregulation is the set of physiological processes that help maintain body temperature within a functional range. During exercise, muscles generate heat as they use energy. The body must transfer enough heat to the environment to prevent excessive heat storage.
In warm conditions, the body generally increases skin blood flow and sweat production. Blood carries heat toward the skin, while evaporation of sweat can remove heat from the body’s surface.
How effectively this works depends on the environment as well as the individual. Ambient temperature, humidity, air movement, solar radiation, clothing, exercise intensity, and acclimatization can all affect the thermal load and the body’s ability to dissipate heat.
5.1 Sweating is a heat-loss mechanism
Sweat production is an important thermoregulatory response. However, producing sweat and evaporating sweat are not the same thing. In humid conditions, sweat may evaporate less effectively, so a person can sweat heavily without achieving proportionate cooling.
Sweat rate also varies substantially between individuals and across environmental conditions. It is not a direct measurement of mitochondrial activity, AMPK signaling, MOTS-c concentration, or exercise efficiency.
5.2 Cardiovascular strain during heat exposure
Exercise in the heat increases the need to support both working muscles and skin blood flow. As sweating continues, fluid losses can reduce plasma volume, adding to cardiovascular strain and making it more difficult to maintain the same exercise intensity.
Dehydration can further impair heat dissipation and increase the physiological demands of exercise. Under sufficiently severe conditions, heat stress can contribute to heat-related illness.
These mechanisms are supported by human exercise-physiology research. They do not require MOTS-c to explain them, and no established evidence shows that administered MOTS-c prevents these responses.
6. What Happens During Exercise in Mui Ne’s Warm Environment?
Mui Ne is a useful contextual example because outdoor exercise in a warm coastal setting may involve substantial thermal exposure. The actual physiological load depends on conditions at the time, including humidity, sunlight, wind, activity intensity, clothing, and individual acclimatization.
It is important not to treat a place name as a physiological measurement. The same location can present different levels of heat stress at different times of day or under different weather conditions.
6.1 Environmental heat and metabolic heat are additive challenges
Exercise produces metabolic heat internally. The environment also influences how quickly the body can transfer that heat to the surroundings. When the environment is hot, the temperature gradient available for heat loss may be reduced, and sweating becomes more important.
If humidity limits evaporation, the body may accumulate heat even when sweat production is high. This illustrates why sweat volume alone cannot indicate whether thermoregulation is effective.
6.2 Heat exposure is not evidence of MOTS-c activation
Heat exposure may affect many cellular and systemic responses, but it should not automatically be assumed to activate MOTS-c in a specific way in humans. The response of a mitochondrial-derived peptide to exercise or metabolic stress does not establish that it is a direct sensor of environmental temperature.
To establish a relationship, researchers would need to measure MOTS-c under defined heat-exposure conditions and evaluate its relationship with relevant physiological outcomes.
7. Is MOTS-c a Thermoregulatory Peptide?
At present, it is more accurate to describe MOTS-c as a mitochondrial-derived peptide under investigation for its potential roles in metabolic regulation and cellular stress signaling than to call it a proven thermoregulatory peptide.
A direct thermoregulatory claim would require evidence that MOTS-c affects one or more defined aspects of temperature control. Examples might include changes in core temperature under controlled conditions, sweat responses, skin blood flow, heat storage, or tolerance of a standardized exercise challenge in the heat.
Even a measurable change in one of these variables would need careful interpretation. For example, a change in sweating could have different implications depending on the environment and whether sweat is effectively evaporating.
Current evidence does not establish that administered MOTS-c improves these outcomes in humans. Research on cellular stress and metabolic pathways provides a reason to investigate the question, not a basis for asserting the answer.
7.1 What a convincing study would need
A human study designed to test a thermoregulatory effect would need to distinguish the effect of MOTS-c from the effects of exercise, environmental heat, hydration, acclimatization, and other relevant factors.
Depending on the hypothesis, the study could measure:
- core and skin temperature under controlled environmental conditions;
- sweat rate and the efficiency of evaporative heat loss;
- cardiovascular responses during standardized exercise;
- fluid balance and relevant indicators of hydration;
- exercise capacity or perceived exertion; and
- adverse events and evidence of product exposure or biological activity.
These are examples of research endpoints, not a validated MOTS-c testing protocol. Until suitable studies report results, a thermoregulatory benefit should be considered unproven.
8. What Do Reviews of MOTS-c Research Actually Support?
Reviews published in 2021 and 2023 describe MOTS-c as a candidate metabolic signaling peptide associated with the folate–AICAR–AMPK pathway, cellular stress responses, and experimental models of metabolic dysfunction.
They also discuss potential connections with exercise and aging. However, a review that summarizes a broad range of possible biological roles does not mean that each role has been established in humans.
The distinction is particularly important for thermoregulation because evidence can be several steps removed from a direct clinical outcome:
- A laboratory study may demonstrate an effect on a molecular pathway.
- An animal study may report a change in metabolic function or exercise performance.
- An observational human study may identify an association between endogenous MOTS-c and a physiological condition.
- A controlled human intervention study would be needed to establish whether an administered product causes a defined benefit and what risks accompany it.
These forms of evidence are complementary, but they are not interchangeable. A mechanistic finding cannot substitute for a clinical trial, and a biomarker association cannot establish that administering the same molecule produces a benefit.
9. Safety and Regulatory Considerations
Potential metabolic activity does not establish that an experimental peptide is safe for administration. Safety evaluation requires evidence about the material itself, how it behaves in the body, the dose and exposure, potential adverse effects, and the quality of the formulation.
In its 2026 assessment of MOTS-c-related bulk drug substances nominated for compounding in the United States, the U.S. Food and Drug Administration reported that it had not identified publicly available human clinical studies or human exposure data for these substances administered by any route. The assessment also raised concerns related to characterization, impurities, aggregation, and potential immunogenicity.
This is a U.S.-specific regulatory assessment concerning the substances considered for compounding. It should not be presented as a determination of Vietnamese law or as proof that every product sold under the MOTS-c name has an identical composition or risk profile.
It does, however, highlight important gaps in the evidence base. Without adequate human exposure and safety data, claims about the benefits of administering MOTS-c for metabolism, exercise, aging, or thermoregulation cannot be treated as established clinical conclusions.
A research-grade label alone does not demonstrate pharmaceutical equivalence to the material used in a published study. Nor does a purity result alone establish sterility, stability, safety, or clinical effectiveness.
Even if a peptide’s chemical identity and purity were adequately established, those results would not prove that it is effective or safe for human use. Identity, impurities, formulation quality, pharmacology, clinical outcomes, and adverse effects are distinct parts of a complete evidence assessment.
10. Established Heat-Safety Research Versus Experimental MOTS-c Research
Research on exercise in hot environments has produced consensus recommendations addressing heat acclimatization, hydration, cooling, and recognition of heat-related illness. These recommendations are supported by a different and more directly applicable evidence base than the current MOTS-c literature.
The International Olympic Committee consensus statement on sport events in the heat emphasizes environmental risk assessment, heat acclimatization, hydration management, appropriate warm-up and clothing, cooling strategies, and medical management of exertional heat stroke.
These measures are relevant because heat stress can impair performance and, in severe cases, threaten health. They should not be replaced by assumptions about experimental mitochondrial peptides.
For readers evaluating MOTS-c claims, the key comparison is not whether the peptide sounds biologically plausible. It is whether the claimed benefit has been demonstrated with an appropriate endpoint and a suitable study design.
| Research topic | What is supported | What remains uncertain |
|---|---|---|
| MOTS-c molecular biology | MOTS-c is a mitochondrial-derived peptide studied in relation to metabolic signaling and cellular stress. | Its complete physiological role in humans and the clinical significance of many reported mechanisms. |
| MOTS-c and AMPK | Experimental studies support a relationship with folate–AICAR–AMPK signaling. | Whether administering MOTS-c produces a clinically meaningful benefit through this pathway in humans. |
| Endogenous MOTS-c and exercise | Reviews describe evidence that acute exercise can alter some mitochondrial-derived peptide responses. | Whether these changes cause training adaptation or predict response to an administered peptide. |
| Human thermoregulation | Heat exposure affects sweating, skin blood flow, cardiovascular strain, and heat-loss capacity. | Whether MOTS-c directly changes any of these responses in humans. |
| Heat acclimatization | Repeated, appropriately managed exposure to heat can improve physiological tolerance to exercising in hot conditions. | Whether MOTS-c has any additional effect on heat acclimatization or its clinical outcomes. |
| Administered MOTS-c products | Preclinical research provides hypotheses for further investigation. | Human pharmacokinetics, appropriate exposure, efficacy, dose-response, immunogenicity, and longer-term safety. |
11. Statistics and Evidence Snapshot
| Study or source | Evidence type | Key result or conclusion | Interpretation limit |
|---|---|---|---|
| Lee et al., 2015 | Discovery and experimental research | Identified MOTS-c as a 16-amino-acid mitochondrial-derived peptide and reported metabolic effects involving AMPK-associated signaling in experimental models. | Does not establish a human thermoregulatory effect. |
| Merry et al., 2021 | Review of mitochondrial-derived peptides and exercise | Summarized evidence that some MDP responses can change during or after acute exercise, while causal roles in exercise adaptation remained unresolved. | A review of exercise-responsive biomarkers is not proof that an administered peptide improves performance. |
| Wan et al., 2023 | Mechanistic review | Discussed MOTS-c signaling in metabolic regulation, stress responses, and aging-related research. | The breadth of topics reviewed does not mean all proposed benefits are clinically established. |
| Racinais et al., 2015 | Consensus statement on exercise in heat | Identified thermoregulatory strain, dehydration, and the importance of heat acclimatization, hydration, and cooling. | Provides general heat-safety evidence, not evidence about MOTS-c. |
| IOC consensus, 2023 | Consensus statement on sport events in heat | Outlined measures for environmental monitoring, athlete behavior, hydration, acclimatization, cooling, and medical management of heat illness. | Does not establish a role for mitochondrial-derived peptides in heat protection. |
| FDA assessment, 2026 | Regulatory and safety assessment of MOTS-c-related bulk substances | Reported no identified publicly available human clinical studies or human exposure data for the nominated substances and raised quality and safety concerns. | Specific to the U.S. regulatory assessment; it is not a determination of Vietnamese law. |
12. Frequently Asked Questions
MOTS-c is a short peptide encoded within mitochondrial DNA. It is studied as a signaling molecule that may participate in metabolic regulation and cellular responses to stress.
It has not been established as a direct regulator of human thermoregulation. Current research focuses mainly on mitochondrial signaling, metabolic regulation, and cellular stress responses. A direct effect on human core temperature, sweating, or heat tolerance has not been demonstrated.
Experimental research has linked MOTS-c with the folate–AICAR–AMPK pathway. AMPK is involved in cellular energy sensing, but this mechanism does not prove that administering MOTS-c produces a useful clinical outcome.
Reviews report that some mitochondrial-derived peptide responses, including MOTS-c-related responses, can change with acute exercise. Results depend on the protocol, tissue, and timing. A change in endogenous peptide levels does not establish that the peptide causes the benefits of exercise.
No established human evidence demonstrates that administering MOTS-c improves heat tolerance in Mui Ne or another hot environment. Heat-related responses are influenced by environmental conditions, exercise intensity, hydration, and acclimatization.
No. Sweating is primarily a thermoregulatory response and is not a validated marker of MOTS-c activity, AMPK activation, or mitochondrial efficiency.
No. Animal studies can help identify biological mechanisms and generate hypotheses, but they do not establish human efficacy, appropriate dosing, pharmacokinetics, or safety.
Endogenous MOTS-c is produced within the biological system. An administered product raises additional questions about identity, formulation, absorption, distribution, biological activity, and safety. Evidence about endogenous MOTS-c cannot automatically establish the effects of an externally supplied peptide.
The U.S. FDA assessment of nominated MOTS-c-related bulk substances identified gaps in human exposure data and concerns involving characterization, impurities, aggregation, and potential immunogenicity. This is a U.S.-specific assessment and should not be presented as a statement of Vietnamese law.
No evidence supports that substitution. Established heat-safety research emphasizes appropriate acclimatization, hydration management, cooling, and recognition of heat-related illness.
Appropriately designed human intervention studies would need to measure defined thermoregulatory outcomes under controlled conditions, characterize the administered material, include suitable comparison groups, and evaluate safety. A change in a molecular marker alone would not establish a meaningful clinical benefit.
No. The phrase does not independently establish regulatory approval, pharmaceutical equivalence, sterility, safety, or efficacy. Product claims must be assessed separately from the findings of published research.
13. Related Research Products and Educational Resources
MOTS-C 20mg — Research Product Information
This listing relates to MOTS-c, the mitochondrial-derived peptide discussed in this article. A product listing does not establish verified identity, purity, sterility, regulatory approval, clinical efficacy, or suitability for human use. Published findings apply to the specific material and experimental conditions studied.
SLU-PP-332 5mg — Related Exercise-Mimetic Research
SLU-PP-332 is an experimental compound studied in relation to exercise-associated metabolic pathways. It is distinct from MOTS-c, and evidence for one compound cannot be transferred automatically to the other. The term “exercise mimetic” describes a research concept, not proof of equivalent benefits or safety in humans.
- Knowledge Hub — explore peptide biology, mechanisms, and clinical evidence.
- Peptide FAQ — review general questions about research peptides and the limits of product claims.
- Peptide Products and Research Information — distinguish product descriptions from independently established scientific findings.
Related Educational Resource: Longevity Peptide Plan
The Longevity Peptide Plan is a related educational resource for readers exploring longevity-focused peptide research. It is not a personalized treatment recommendation and does not establish that MOTS-c extends human lifespan or improves thermoregulation.
14. Scientific References
- Lee C, Zeng J, Drew BG, et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism. 2015;21(3):443–454. DOI: 10.1016/j.cmet.2015.02.009. Journal article.
- Merry TL, Chan A, Woodhead JST, Reynolds JC, Kumagai H, Kim SJ, Lee C, Ghosh P, Emanuele E, Sweeney G, Philp A. Mitochondrial-derived peptides and exercise. Biochimica et Biophysica Acta (BBA) – General Subjects. 2021;1865(12):130011. PubMed record.
- Wan W, Zhang L, Lin Y, Rao X, Wang X, Hua F, et al. Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. Journal of Translational Medicine. 2023;21:36. DOI: 10.1186/s12967-023-03885-2. Journal article.
- Merry TL, Chan A, Woodhead JST, et al. Mitochondrial-derived peptides in energy metabolism. American Journal of Physiology-Endocrinology and Metabolism / review literature. 2020. Full-text review.
- Zheng Y, Wei Z, Wang T. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Frontiers in Endocrinology. 2023;14:1120533. DOI: 10.3389/fendo.2023.1120533. Journal article.
- Racinais S, Alonso JM, Coutts AJ, et al. Consensus recommendations on training and competing in the heat. Sports Medicine. 2015;45(7):925–938. DOI: 10.1007/s40279-015-0343-6. Full text.
- Racinais S, Hosokawa Y, Akama T, et al. IOC consensus statement on recommendations and regulations for sport events in the heat. British Journal of Sports Medicine. 2023;57(1):8–25. DOI: 10.1136/bjsports-2022-105942. PubMed record.
- U.S. Food and Drug Administration. Evaluation of MOTS-c-related bulk drug substances for inclusion on the 503A Bulk Drug Substances List. FDA assessment, 2026. FDA assessment document.
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Regulatory background on bulk drug substances and compounding assessments. FDA resource.
Conclusion: MOTS-c Is a Research Candidate, Not an Established Heat-Tolerance Intervention
MOTS-c is a mitochondrial-derived peptide with experimental links to metabolic regulation, AMPK-associated signaling, and cellular stress responses. Research on endogenous mitochondrial-derived peptides also suggests that exercise can alter some of these biological signals. These findings help explain why MOTS-c remains an active subject of mitochondrial and metabolic research.
However, the evidence does not establish that MOTS-c is a direct regulator of human thermoregulation. There is no established human clinical evidence that administering MOTS-c improves sweat responses, lowers core temperature, enhances heat acclimatization, or prevents heat-related illness.
In Mui Ne and other warm environments, exercise places additional demands on circulation, temperature control, and fluid balance. Established sports-medicine research supports heat acclimatization, appropriate hydration, cooling strategies, and recognition of heat-related illness. Experimental mitochondrial peptides should not be treated as substitutes for these measures.
The key principle: biological plausibility is not clinical proof. MOTS-c is a promising research topic in mitochondrial signaling, but its relationship with human thermoregulation—and the safety and efficacy of administered MOTS-c products—requires direct, well-designed human studies.